Alocyte (0412e1)

**Alocyte** is an investigational, minimally manipulated human umbilical cord blood-derived cellular product comprising cord blood plasma and cord blood mononuclear cells. It is being evaluated as a locally administered regenerative treatment for chronic facetogenic back pain through intra-articular injection into affected spinal facet joints. The registered Phase 1 dose-escalation study describes intended pro-angiogenic, immunomodulatory, anti-inflammatory, metabolic-supportive, and tissue-repair activities, but no single validated molecular target or definitive clinical mechanism has been established. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05909709))

Other names

Alocyte